Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (11) · 1567-1568
DOI: 10.1111/apt.70672 ↗Kurz gefasst
Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 15.04.2026. Verfasst von Runqi Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of General Surgery, Baoshan Branch, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Runqi Wang, Zhe Cui
Zitieren
APA
Wang, R., Cao, D., & Cui, Z. (2026). Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics, 63(11), 1567-1568. https://doi.org/10.1111/apt.70672
Vancouver
Wang R, Cao D, Cui Z. Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;63(11):1567-1568. doi:10.1111/apt.70672
BibTeX
@article{Wang2026,
author = {Wang, Runqi and Cao, Dongxing and Cui, Zhe},
title = {Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {11},
pages = {1567--1568},
doi = {10.1111/apt.70672}
}
EUVIMED